scholarly article | Q13442814 |
P2093 | author name string | Ueda A | |
Tada Y | |||
Niho Y | |||
Mayumi T | |||
Nagasawa K | |||
Ishii Y | |||
Kusaba T | |||
Yamauchi Y | |||
P2860 | cites work | The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 |
Avascular necrosis in SLE. An apparent predilection for young patients | Q30445300 | ||
Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant | Q33478061 | ||
Early treatment of avascular necrosis in systemic lupus erythematosus | Q33556858 | ||
THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS DESPITE CIRCULATING ANTICOAGULANTS | Q34540619 | ||
A vascular necrosis of the femoral head in childhood systemic lupus erythematosus. | Q35939707 | ||
Ischemic heart disease in systemic lupus erythematosus in the young patient: report of six cases | Q39564600 | ||
Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus | Q42229554 | ||
Ischemic necrosis of bone in systemic lupus erythematosus | Q43785222 | ||
A nation-wide study of atherosclerosis in infants, children and young adults in Japan | Q44579274 | ||
Thromboembolic complications associated with ACTH and cortisone therapy. | Q51050822 | ||
Hip problems associated with organ transplants | Q53678821 | ||
Histologic demonstration of fat emboli in aseptic necrosis associated with hypercortisonism. | Q54742649 | ||
Aseptic necrosis of bone in systemic lupus erythematosus. Relationship to corticosteroid therapy | Q67324402 | ||
Platelet function and coagulation profile in lupus erythematosus. Studies in 50 patients | Q68347345 | ||
Avascular necrosis of bone in systemic lupus erythematosus | Q69810959 | ||
Avascular necrosis of bone after renal transplantation | Q69930138 | ||
The lupus anticoagulant. A disease marker in antinuclear antibody negative lupus that is cross-reactive with autoantibodies to double-stranded DNA | Q69937135 | ||
Mechanisms of abnormal platelet aggregation in systemic lupus erythematosus | Q70446517 | ||
Non-traumatic necrosis of the femoral head. I. Relation of altered hemostasis to etiology | Q71493334 | ||
Systemic lupus erythematosus (SLE) and aseptic bone necrosis. A discussion based on the presentation of one case treated with corticosteroids | Q72229808 | ||
ARTHRITIS ROUNDS. (4). ASEPTIC NECROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS. REPORT OF A CASE INVOLVING SIX JOINTS | Q77121985 | ||
ASEPTIC NECROSIS OF THE FEMORAL HEADS AFTER HIGH-DOSAGE CORTICOSTEROID THERAPY | Q77227364 | ||
Avascular necrosis of the femoral and humeral heads after high-dosage corticosteroid therapy | Q78875182 | ||
Avascular (aseptic) bone necrosis associated with systemic lupus erythematosus | Q78927175 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | systemic lupus erythematosus | Q1485 |
P304 | page(s) | 672-676 | |
P577 | publication date | 1989-08-01 | |
P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
P1476 | title | Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities | |
P478 | volume | 48 |
Q34481574 | Anticoagulant therapy for osteonecrosis associated with heritable hypofibrinolysis and thrombophilia |
Q37045158 | Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview |
Q36413522 | Bilateral Knee Pain Associated with Bone Infarction in a Patient with Behcet's Disease |
Q37968681 | Corticosteroid-associated avascular necrosis: dose relationships and early diagnosis |
Q33364063 | Development of Perthes' disease in a 3-year-old boy with idiopathic thrombocytopenic purpura and antiphospholipid antibodies |
Q38046465 | Does vasculitis alone cause AVN? A review of literature |
Q41832446 | High-Dose Intravenous Methylprednisolone Therapy Associated with Osteonecrosis in Patients with Systemic Lupus Erythematosus |
Q73025113 | Kienböck's disease in systemic lupus erythematosus |
Q40665188 | Lupus nephritis in childhood and adolescence |
Q33893360 | Management of osteonecrosis in systemic lupus erythematosus |
Q72009136 | Musculoskeletal complications of systemic lupus erythematosus in the hopkins lupus cohort: An update |
Q38753531 | Musculoskeletal manifestations of the antiphospholipid syndrome |
Q41663457 | Non-corticosteroid risk factors of symptomatic avascular necrosis of bone in systemic lupus erythematosus: A retrospective case-control study |
Q36149928 | Orthopaedic manifestations of the antiphospholipid (Hughes) syndrome |
Q36960917 | Orthopedic involvement in antiphospholipid syndrome |
Q53304418 | Osteonecrosis of the hip in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome. |
Q37655516 | Osteonecrosis secondary to antiphospholipid syndrome: a case report, review of the literature, and treatment strategy |
Q33498327 | Pathogenesis and treatment of the antiphospholipid antibody syndrome |
Q41919918 | Prevalence, incidence, and associated factors of avascular necrosis in Korean patients with systemic lupus erythematosus: a nationwide epidemiologic study |
Q46742951 | Regenerative effects of transplanting autologous mesenchymal stem cells on corticosteroid-induced osteonecrosis in rabbits |
Q84743064 | Risk factors for avascular bone necrosis in patients with systemic lupus erythematosus |
Q35549358 | Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: is there a role for antiphospholipid antibodies? |
Q42955929 | Subchondral insufficiency fracture of the femoral head in a patient with systemic lupus erythematosus |
Q57603185 | Symptomatic knee osteonecrosis in patients with systemic lupus erythematosus: a case–control study |
Q35637240 | Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study |
Q33567393 | The antiphospholipid syndrome: a syndrome in evolution |
Q28277894 | The pathophysiology of alveolar osteonecrosis of the jaw: anticardiolipin antibodies, thrombophilia, and hypofibrinolysis |
Q53145049 | The risk factors of avascular necrosis in patients with systemic lupus erythematosus: a meta-analysis. |
Q36324102 | The use of joint-specific and whole-body MRI in osteonecrosis: a study in patients with juvenile systemic lupus erythematosus |
Q39199424 | Time trend and risk factors of avascular bone necrosis in patients with systemic lupus erythematosus |
Q38235184 | Treatment of osteonecrosis in systemic lupus erythematosus: a review |
Q33348373 | Unusual manifestations of the antiphospholipid syndrome |
Q46526220 | Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRI. |
Q84600252 | [Osteonecrosis. What is new?] |
Search more.